These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11858078)

  • 21. [Causes of failures in the clinical treatment of open pulmonary tuberculosis and possibilities of their removal from the standpoint of the expense bearer].
    Hoppe R
    Beitr Klin Erforsch Tuberk Lungenkr; 1969; 140(1):101-5. PubMed ID: 5824356
    [No Abstract]   [Full Text] [Related]  

  • 22. [Use of isofon in combined treatment of patients with acutely progressive forms of tuberculosis].
    Chelnokova OG; Kibrik BS
    Probl Tuberk Bolezn Legk; 2003; (9):12-4. PubMed ID: 14598518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Use of anabolic steroids in the complex treatment of patients with destructive pulmonary tuberculosis].
    Bilyk MA
    Vrach Delo; 1985 Mar; (3):19-21. PubMed ID: 4013154
    [No Abstract]   [Full Text] [Related]  

  • 24. [Up-to-date technologies in preoperative preparation and postoperative period in patients with progressive destructive pulmonary tuberculosis].
    Karpina NL; Lepekha LN; Zhillin IuN; Erokhin VV
    Probl Tuberk Bolezn Legk; 2008; (9):25-8. PubMed ID: 19062568
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [New technologies in the determination of drug susceptibility in Mycobacterium tuberculosis].
    Skotnikova OI; Mikhaĭlovich VM; Nosova EIu; Lapa SA; Griadunov DA; Donnikov MIu; Badleeva MV; Galkina KIu; Dorozhkova IR; Litvinov VI; Zasedatelev AS; Moroz AM; Mirzabekov AD
    Probl Tuberk Bolezn Legk; 2004; (6):40-2. PubMed ID: 15315132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Efficacy of chemotherapy for tuberculosis in patients who isolate drug-resistant strains of M. tuberculosis with different genotypes].
    Vasil'eva IA; Andreevskaia SN; Smirnova TG; Chernousova LI; Chukanov VI
    Probl Tuberk Bolezn Legk; 2004; (8):25-8. PubMed ID: 15478554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Efficiency of the use of peppermint (Mentha piperita L) essential oil inhalations in the combined multi-drug therapy for pulmonary tuberculosis].
    Shkurupiĭ VA; Kazarinova NV; Ogirenko AP; Nikonov SD; Tkachev AV; Tkachenko KG
    Probl Tuberk; 2002; (4):36-9. PubMed ID: 12125251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors associated with drug resistance in pulmonary tuberculosis.
    Johnson J; Kagal A; Bharadwaj R
    Indian J Chest Dis Allied Sci; 2003; 45(2):105-9. PubMed ID: 12715932
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Peribronchial lymphotropic therapy in the combined treatment of patients with progressive pulmonary tuberculosis].
    Pletnev GV; Krasnov DV
    Probl Tuberk Bolezn Legk; 2003; (12):3-5. PubMed ID: 15004961
    [No Abstract]   [Full Text] [Related]  

  • 30. [Pulmonary tuberculosis in elderly patients].
    Shiraishi Y
    Kyobu Geka; 2005 Jul; 58(8 Suppl):724-8. PubMed ID: 16097626
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Primary resistance in pulmonary tuberculosis].
    Vuga D
    Riforma Med; 1965 Oct; 79(40):1113-4. PubMed ID: 5861633
    [No Abstract]   [Full Text] [Related]  

  • 32. [Epidemiological and clinical aspects of massive bacillary excretion in tuberculosis under modern conditions].
    Rudoĭ NM; Eliseev VV; Asambaev AA; Temirgalieva RU
    Probl Tuberk; 1970; 48(11):8-13. PubMed ID: 5516524
    [No Abstract]   [Full Text] [Related]  

  • 33. Drug-resistant tuberculosis.
    Nations JA; Lazarus AA; Walsh TE
    Dis Mon; 2006; 52(11-12):435-40. PubMed ID: 17157616
    [No Abstract]   [Full Text] [Related]  

  • 34. [Significance of determination of drug resistance in Mycobacterium tuberculosis for successful treatment of pulmonary tuberculosis].
    Novozhilova IA
    Probl Tuberk Bolezn Legk; 2004; (4):29-31. PubMed ID: 15171041
    [No Abstract]   [Full Text] [Related]  

  • 35. [Extracorporeal antiaggregant pharmacotherapy in the treatment of acutely progressive forms of tuberculosis].
    Kibrik BS; Chelnokova OG
    Probl Tuberk Bolezn Legk; 2007; (11):14-9. PubMed ID: 18084833
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pulmonary tuberculosis in adolescents in relation to different degree of drug resistance].
    Firsova VA; Rusakova LI; Poluéktova FG; Iatskova TV; Ryzhova AP; Kobulashvili MG
    Probl Tuberk; 2002; (12):23-5. PubMed ID: 12611330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Physiotherapeutic methods in the complex treatment of patients with pulmonary tuberculosis].
    Savula MM; Kravchenko NS
    Probl Tuberk; 1991; (6):70-3. PubMed ID: 1780318
    [No Abstract]   [Full Text] [Related]  

  • 38. Drug resistance in tuberculosis in Delhi: a 2 year profile (2001--2002).
    Negi SS; Gupta S; Lal S
    J Commun Dis; 2003 Jun; 35(2):74-81. PubMed ID: 15562952
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Complex influence of chemo- and ozonotherapy on the immunity of patients with destructive pulmonary tuberculosis].
    Platonova IL; Ivanov GA; Pisarenko Ei; Purskaia MB; Shchurko GV; Toporovich OI; Tkach EA; Pavlenko OV; Grechukha NR
    Probl Tuberk Bolezn Legk; 2008; (2):20-3. PubMed ID: 18376471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Therapeutic plasmapheresis in patients with destructive pulmonary tuberculosis].
    Karpova NL; Naumov VN; Shaĭkhaev AIa; Titiukhina MV; Sigaev AT; Enilenis II
    Probl Tuberk Bolezn Legk; 2006; (6):14-7. PubMed ID: 16881228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.